BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8099251)

  • 1. Effect of ebrotidine on gastric mucosal calcium channel activity.
    Slomiany BL; Liu J; Kawai T; Czajkowski A; Slomiany A
    Am J Gastroenterol; 1993 Jun; 88(6):881-6. PubMed ID: 8099251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of gastric mucosal calcium channel activity by an antiulcer agent, ebrotidine.
    Slomiany BL; Liu J; Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A
    J Physiol Pharmacol; 1994 Mar; 45(1):121-31. PubMed ID: 7519082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of EGF-induced gastric mucosal calcium channel phosphorylation by ebrotidine.
    Slomiany BL; Liu J; Piotrowski J; Slomiany A
    Biochem Int; 1992 Dec; 28(4):751-60. PubMed ID: 1282815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of gastric mucosal calcium channel activity by sucralfate.
    Slomiany BL; Liu J; Slomiany A
    Biochem Int; 1992 Dec; 28(6):1125-34. PubMed ID: 1283940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of gastric mucosal calcium channels activity by platelet-derived growth factor.
    Slomiany BL; Liu J; Fekete Z; Piotrowski J; Slomiany A
    J Physiol Pharmacol; 1992 Dec; 43(4):333-44. PubMed ID: 1284109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ebrotidine on gastric mucosal EGF and PDGF receptor expression.
    Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1993 Aug; 30(6):1127-34. PubMed ID: 8106073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucus glycoprotein regulation of gastric mucosal calcium channel activity.
    Slomiany BL; Liu J; Grabska M; Slomiany A
    Biochem Mol Biol Int; 1993 Jan; 29(1):5-15. PubMed ID: 8387847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of buccal mucosal calcium channel activity by salivary mucins.
    Slomiany BL; Fekete Z; Murty VL; Slomiany A
    J Physiol Pharmacol; 1993 Sep; 44(3):199-211. PubMed ID: 7694688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroprotective properties of ebrotidine. A review.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):459-67. PubMed ID: 9205744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sucralfate on gastric mucosal calcium channels activity.
    Liu J; Slomiany A; Slomiany BL
    Gen Pharmacol; 1992 Nov; 23(6):1129-33. PubMed ID: 1283137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of gastric mucosal calcium channels by epidermal growth factor.
    Liu J; Fekete Z; Slomiany A; Slomiany BL
    Int J Biochem; 1993 Jan; 25(1):29-35. PubMed ID: 8381750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists.
    Palop D; Romero A; Villamayor F; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):450-4. PubMed ID: 9205742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ebrotidine--a new H2-receptor antagonist with mucosal strengthening activity.
    Piotrowski J; Yamaki K; Morita M; Slomiany A; Slomiany BL
    Biochem Int; 1992 Mar; 26(4):659-67. PubMed ID: 1351724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric mucosal EGF and PDGF receptor expression with ulcer healing by ebrotidine.
    Slomiany BL; Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A
    Am J Gastroenterol; 1994 Jun; 89(6):894-7. PubMed ID: 8198101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM1-ganglioside regulation of EGF-induced gastric mucosal calcium channel activation.
    Slomiany BL; Liu J; Yao P; Slomiany A
    Gen Pharmacol; 1992 Sep; 23(5):799-803. PubMed ID: 1385258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the cytoprotective and antisecretory activity of ebrotidine. A review.
    Konturek PC; Brzozowski T; Konturek SI; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):578-89. PubMed ID: 9205769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary mucin modulation of buccal mucosal calcium channel activity.
    Slomiany BL; Fekete Z; Piotrowski J; Murty VL; Slomiany A
    Biochem Mol Biol Int; 1993 Feb; 29(2):221-31. PubMed ID: 8388291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived growth factor activation of gastric mucosal calcium channels.
    Slomiany BL; Liu J; Slomiany A
    Biochem Biophys Res Commun; 1992 Aug; 186(3):1496-502. PubMed ID: 1380805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.